What's New
What to Do About… FTD, the Most Common Dementia Under 60
Partners in FTD Care, Summer 2021 Download the full issue (pdf) Frontotemporal degeneration is most commonly diagnosed between the ages of 45 and 64, and is the most common dementia under…
Protein Replacement Therapy May Be Useful in Treating FTD-GRN, Recent Study Finds
Preclinical studies analyzing GRN mutations in FTD have uncovered a new approach to enhancing the brain’s intake of progranulin, a commonly mutated protein linked to genetic forms of FTD. As…
Skin Cells from Persons with FTD May Help Understand Disease Mechanisms, Study Finds
The skin cells of persons diagnosed with FTD may help in understanding the molecular mechanisms of the disease, a recent study from the University of Eastern Finland shows. The study,…
A Community Update from AFTD’s CEO
An Update from AFTD’s CEO on Diversity, Equity, and Inclusion in Our Work In July 2020, AFTD shared a public statement regarding diversity, equity, and inclusion in our work. We…
AFTD News: Summer 2021, Vol. 18, Issue 2
In this issue: AFTD’s 2021 Education Conference Offers Resources, Support, Hope; ALLFTD Study Recruiting Participants to Help Further Understanding of FTD; Spotlight on… Rita Choula, AFTD Board of Directors; AFTD…
Add Your Voice to a Global Conversation on FTD
World FTD Awareness Week 2021 is fast approaching – it will be held September 26th through October 3rd. In collaboration with World FTD United, AFTD is working to make sure…
Finding Support and Giving Back
“AFTD is helping more people understand what it is like to live with FTD, and giving hope to the people who need it.” – Reverend Randy Ledbetter, FTD care partner…
Giving a Hand to Our Helping Hands! AFTD’s Persons with FTD Advisory Council
“We are passionate about the people with this disease having a voice,” said Amy Shives, speaking on behalf of the AFTD Persons with FTD Advisory Council, of which she is…
AFTD Announces New Drug Discovery Grant and Postdoctoral Fellowship Recipients
AFTD has recently announced new awards supporting research to advance the science of FTD and, hopefully, hasten a future free of this disease. Since 2007, AFTD and the Alzheimer’s Drug…